IL-6 has been shown to be induced in human bronchial epithelial cells following SARS-CoV infection in vitro and in vivo as well as associated with hyper-immune activation during SARS-CoV infection [14], [35], [36]. Here, IL6 is linked to severe acute respiratory syndrome.